Azerbaijan vs Armenia vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 71% | 96% |
| 2023 | 71% | 96% |
| 2022 | 71% | 95% |
| 2021 | 66% | 94% |
| 2020 | 61% | 94% |
| 2019 | 78% | 95% |
| 2018 | 77% | 95% |
| 2017 | 80% | 96% |
| 2016 | 81% | 97% |
| 2015 | 84% | 97% |
| 2014 | 85% | 97% |
| 2013 | 86% | 97% |
| 2012 | 86% | 97% |
| 2011 | 88% | 97% |
| 2010 | 89% | 97% |
| 2009 | 85% | 96% |
| 2008 | 79% | 94% |
| 2007 | 75% | 92% |
| 2006 | 69% | 92% |
| 2005 | 67% | 94% |
| 2004 | 67% | 92% |
| 2003 | 67% | 94% |
| 2002 | 66% | 91% |
| 2001 | 68% | 93% |
| 2000 | 67% | 92% |
| 1999 | 68% | 92% |
| 1998 | 67% | 94% |
| 1997 | 66% | 92% |
| 1996 | 65% | 89% |
| 1995 | 64% | 96% |
| 1994 | 60% | 95% |
| 1993 | 49% | 95% |
| 1992 | 52% | 93% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 51% | 94% |
| 2023 | 51% | 94% |
| 2022 | 51% | 93% |
| 2021 | 49% | 93% |
| 2020 | 56% | 91% |
| 2019 | 74% | 92% |
| 2018 | 74% | 92% |
| 2017 | 76% | 94% |
| 2016 | 78% | 94% |
| 2015 | 79% | 94% |
| 2014 | 78% | 93% |
| 2013 | 78% | 95% |
| 2012 | 79% | 95% |
| 2011 | 82% | 95% |
| 2010 | 81% | 94% |
| 2009 | 81% | 93% |
| 2008 | 81% | 89% |
| 2007 | 79% | 88% |
| 2006 | 78% | 87% |
| 2005 | 75% | 90% |
| 2004 | 77% | 91% |
| 2003 | 77% | 94% |
| 2002 | 76% | 94% |
| 2001 | 77% | 94% |
| 2000 | 76% | 93% |
| 1999 | 75% | 91% |
| 1998 | 73% | 82% |
| 1997 | 70% | 88% |
| 1996 | 74% | 86% |
| 1995 | 74% | 98% |
| 1994 | 69% | 86% |
| 1993 | 66% | 85% |
| 1992 | 58% | 85% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 51% | 94% |
| 2023 | 51% | 94% |
| 2022 | 51% | 96% |
| 2021 | 49% | 93% |
| 2020 | 56% | 92% |
| 2019 | 72% | 92% |
| 2018 | 73% | 92% |
| 2017 | 74% | 94% |
| 2016 | 77% | 94% |
| 2015 | 76% | 94% |
| 2014 | 74% | 93% |
| 2013 | 74% | 95% |
| 2012 | 75% | 95% |
| 2011 | 79% | 95% |
| 2010 | 80% | 94% |
| 2009 | 74% | 93% |
| 2008 | 68% | 89% |
| 2007 | 62% | 85% |
| 2006 | 52% | 78% |
| 2005 | 49% | 91% |
| 2004 | 50% | 91% |
| 2003 | 51% | 93% |
| 2002 | 50% | 91% |
| 2001 | - | 69% |
| 2000 | - | 55% |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 71% of children aged 12–23 months in Azerbaijan and 96% in Armenia: 25 percentage points more in Armenia. The third DTP dose reaches 51% in Azerbaijan and 94% in Armenia, 43 points more in Armenia. The third hepatitis B dose reaches 51% in Azerbaijan and 94% in Armenia, 43 points more in Armenia. In 1992, the first measles dose reached 52% in Azerbaijan and 93% in Armenia, 41 percentage points more in Armenia.
Azerbaijan vs Armenia: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 71% (2024) | 96% (2024) |
| DTP3 | 51% (2024) | 94% (2024) |
| HepB3 | 51% (2024) | 94% (2024) |
Azerbaijan and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Armenia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Azerbaijan and its five neighbors, the latest coverage of the first measles dose is highest in Iran, at 99%, and lowest in Azerbaijan, at 71%; of Armenia and its four neighbors, the latest coverage of the first measles dose is highest in Iran, at 99%, and lowest in Azerbaijan, at 71%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.